A cystatin C test is a blood test that helps estimate how well your kidneys filter waste from your blood. It is often used when the usual kidney blood test, creatinine, might give a misleading picture. That happens in people with unusually low or high muscle mass, older adults with frailty, bodybuilders, amputees, people taking creatine supplements, and some patients whose treatment decisions depend on a more precise kidney estimate.
The test does not replace every kidney test. It adds another angle. Creatinine tells part of the story, cystatin C tells another part, and the most useful result is often an eGFR calculated from both. That combined estimate gives doctors a steadier basis for diagnosing chronic kidney disease, adjusting medicines, evaluating risk, and deciding whether a low eGFR is real or partly caused by the limits of creatinine.
Table of Contents
- What the cystatin C test shows
- Why creatinine sometimes gives the wrong impression
- When cystatin C gives a better picture
- How to read cystatin C and eGFR results
- What it means when creatinine and cystatin C disagree
- Limits and factors that affect accuracy
- How to prepare and what to ask your doctor
- How cystatin C fits into kidney care
What the cystatin C test shows
Cystatin C is a small protein made by most cells in your body. Your kidneys filter it from the blood through tiny filtering units called glomeruli. When kidney filtration slows, cystatin C builds up in the blood. A higher cystatin C level usually points to lower kidney filtration.
The result is most useful when the lab uses cystatin C to calculate an estimated glomerular filtration rate, or eGFR. GFR means the rate at which the kidneys filter blood. Because direct GFR measurement is expensive, time-consuming, and usually done only in special settings, most routine care uses estimated GFR from blood markers.
You might see three different kidney estimates on a lab report:
| Result name | What it uses | Best use |
|---|---|---|
| eGFRcr | Creatinine, age, and sex | Routine kidney screening and monitoring |
| eGFRcys | Cystatin C, age, and sometimes sex depending on equation | A second estimate when creatinine looks unreliable |
| eGFRcr-cys | Both creatinine and cystatin C | Often the most accurate routine estimate for adults |
Creatinine-based eGFR is still the most common because creatinine is cheap, widely available, and included in routine metabolic panels. Cystatin C is ordered separately in many clinics. Some labs report only the cystatin C number in mg/L. Others automatically report eGFRcys or the combined eGFRcr-cys when both creatinine and cystatin C are available.
The raw cystatin C number is less useful by itself than the eGFR calculated from it. Normal ranges vary by lab and method. A cystatin C of 1.1 mg/L might be interpreted differently depending on age, the equation used, and the lab’s calibration. The eGFR result gives the practical kidney-function estimate doctors use for staging, medication decisions, and trend monitoring.
Cystatin C is also useful because it is less tied to muscle mass than creatinine. That is the main reason doctors order it. It gives a second look when a creatinine result seems too high, too low, or out of step with the person’s real health picture.
Why creatinine sometimes gives the wrong impression
Creatinine comes from normal muscle metabolism. Muscles make creatine phosphate for energy, and creatinine is a breakdown product. The kidneys clear creatinine from the blood, so a rising creatinine level often signals weaker filtration. The problem is that creatinine reflects both kidney function and muscle-related factors.
A muscular person naturally produces more creatinine. Their creatinine level might look high even when kidney filtration is normal. A frail older adult, a person with severe weight loss, or someone with very low muscle mass produces less creatinine. Their creatinine can look reassuring even when kidney function is worse than the lab estimate suggests.
That is why creatinine is not a direct kidney-function measurement. It is a marker that works well in many average situations and less well at the edges. A low creatinine does not always mean strong kidneys, and a mildly high creatinine does not always mean kidney disease. A separate explanation of BUN and creatinine blood tests can help if your report includes both values.
Creatinine-based eGFR also shifts with non-kidney factors such as:
- High or low muscle mass
- Recent heavy meat intake
- Creatine supplements
- Bodybuilding or intense resistance training
- Amputation or muscle-wasting conditions
- Severe malnutrition or long illness
- Pregnancy, where kidney filtration normally rises
- Some medicines that affect creatinine handling in the kidney tubules
A common example is an athletic person with a creatinine-based eGFR in the 60s. That result looks close to the chronic kidney disease range, but their high muscle mass might be pushing creatinine up. A cystatin C test gives another estimate that is not driven by muscle in the same way. If the cystatin C-based estimate is much higher, the original creatinine result might have overstated the concern.
The opposite pattern matters too. An 82-year-old with thin arms, low body weight, and a creatinine-based eGFR of 70 might appear to have acceptable kidney function. If cystatin C gives an eGFR of 42, the creatinine estimate probably missed reduced filtration because the person produces little creatinine. That difference affects medication safety, kidney disease staging, and how closely the person should be monitored.
When cystatin C gives a better picture
Cystatin C is most helpful when the creatinine estimate is likely to be distorted or when a decision hinges on a more accurate eGFR. It is not usually ordered just because someone wants “extra labs.” It works best as a targeted test for specific clinical questions.
When muscle mass makes creatinine less reliable
Doctors often consider cystatin C when body build does not match the assumptions behind creatinine-based equations. This includes people who are very muscular, very small, frail, malnourished, or missing a limb. It also includes people with neuromuscular disease, spinal cord injury, long-term immobility, or major weight loss after illness.
In these cases, cystatin C helps answer a practical question: does the creatinine-based eGFR reflect kidney filtration, or mostly body composition? If the creatinine estimate is unexpectedly low in a muscular person, cystatin C helps prevent overdiagnosis. If creatinine looks “normal” in a frail person, cystatin C helps uncover kidney impairment that might otherwise be missed.
People taking creatine sometimes see creatinine rise without a true drop in filtration. Cystatin C is useful here because it is not a breakdown product of creatine. If supplement use is part of the question, the article on creatine and kidney lab changes explains why creatinine can move even when the kidneys are not damaged.
When eGFR is near an important cutoff
A few points on eGFR sometimes change real decisions. A result near 60 can affect whether someone meets the lab definition for chronic kidney disease. A result near 45, 30, or 15 can affect monitoring, referrals, medication choices, imaging decisions, and planning for advanced kidney disease.
Cystatin C is useful when the creatinine-based estimate sits close to one of those cutoffs. For example, a person with an eGFRcr of 58 and no albumin in the urine might not actually have chronic kidney disease if the combined eGFRcr-cys comes back 68 and stays stable. Another person with an eGFRcr of 63 but a combined estimate of 48 needs closer follow-up because the second marker points to more meaningful loss of filtration.
This is especially important for drug dosing. Some medicines need dose changes or extra caution at lower eGFR levels. The exact cutoff varies by medicine, dose, diagnosis, and prescribing guideline, so the result should be interpreted by the clinician managing that treatment.
When kidney disease risk needs clearer staging
Cystatin C helps refine risk in people with possible or known kidney disease. Kidney risk is not based on eGFR alone. Urine albumin, blood pressure, diabetes, heart disease, family history, and the direction of the trend all matter. Still, a more accurate eGFR helps place the person in the right monitoring category.
If you are trying to understand a low kidney estimate, the guide to low eGFR evaluation explains how doctors sort out whether the result is temporary, chronic, or linked to another finding such as protein in the urine.
Cystatin C is also useful in transplant donor evaluation, older adults with several medications, and people whose creatinine result does not match their overall clinical picture. It is not a screening shortcut for every healthy adult. It is a precision tool for cases where the usual estimate leaves too much uncertainty.
How to read cystatin C and eGFR results
A cystatin C report usually includes one or more of three pieces: the cystatin C blood level, the eGFR based on cystatin C, and the combined eGFR based on creatinine plus cystatin C. The combined result is often the one to focus on when both markers are available.
Kidney function is usually grouped into eGFR categories:
| eGFR category | eGFR range | Plain-language meaning |
|---|---|---|
| G1 | 90 or higher | Normal or high filtration, if no other kidney damage is present |
| G2 | 60–89 | Mildly reduced filtration; not CKD by itself without other signs of kidney damage |
| G3a | 45–59 | Mild to moderate reduction |
| G3b | 30–44 | Moderate to severe reduction |
| G4 | 15–29 | Severe reduction |
| G5 | Below 15 | Kidney failure range |
An eGFR below 60 for at least three months supports chronic kidney disease, even without symptoms. An eGFR above 60 does not fully rule out kidney disease if there is persistent albumin in the urine, abnormal urine sediment, structural kidney changes, or a known inherited kidney condition. This is why doctors often pair eGFR with a urine albumin-to-creatinine ratio. The urine test looks for small amounts of albumin, a protein that can leak into urine when the kidney filters are stressed or damaged. A practical explanation of albumin in urine can help make sense of that part of the workup.
Do not judge the result from one number alone. Trends matter. A combined eGFR of 52 that has been stable for two years means something different from a drop from 78 to 52 over a few months. A stable result suggests chronic reduced filtration. A sudden change raises the question of dehydration, medication effects, obstruction, infection, acute kidney injury, or a lab issue.
Age also matters. Kidney filtration tends to decline with age. An eGFR of 62 in a healthy 82-year-old is interpreted differently from the same number in a 32-year-old. That does not mean low eGFR should be ignored in older adults. It means the result should be placed in context with urine albumin, blood pressure, medications, symptoms, and the rate of change.
If your lab report lists cystatin C as “high,” ask whether the eGFRcys or combined eGFR is abnormal. A flagged cystatin C value without an eGFR is harder to use. The action usually comes from the estimated filtration rate, not the raw protein level.
What it means when creatinine and cystatin C disagree
Creatinine and cystatin C do not always produce the same eGFR. A small difference is normal because each marker has its own sources of error. A large difference deserves attention because it often reveals something useful.
The most common patterns are:
| Pattern | Possible explanation | Practical next step |
|---|---|---|
| eGFRcys is higher than eGFRcr | Creatinine may be elevated from higher muscle mass, creatine use, meat intake, or tubular medication effects | Review body build, supplements, diet, medicines, and use the combined estimate |
| eGFRcys is lower than eGFRcr | Creatinine may look falsely reassuring because of low muscle mass, frailty, weight loss, or chronic illness | Check medication dosing, urine albumin, trend, and overall CKD risk |
| Both estimates are low | Reduced kidney filtration is more likely real | Confirm persistence, assess urine albumin, review causes, and plan monitoring |
| Both estimates are normal | Significant filtration loss is less likely | Look at urine albumin and other findings if kidney disease is still suspected |
When the two estimates differ, many clinicians use the combined eGFRcr-cys as the best working estimate. Combining markers balances the weaknesses of each one. Creatinine captures information cystatin C does not, and cystatin C captures information creatinine misses.
A lower cystatin C-based estimate is not automatically proof of kidney damage. It can also reflect non-kidney influences such as inflammation, thyroid problems, steroid use, smoking, obesity, or serious illness. The same caution applies to creatinine: a high creatinine is not automatically kidney disease if the person has high muscle mass or recently changed supplements.
The disagreement itself is clinically useful. It tells the clinician not to rely on autopilot. Instead of accepting the creatinine-based number as final, they can ask: Which marker is more likely to be biased in this person? Does the urine albumin result support kidney damage? Has the eGFR changed over time? Is there a medication or condition that makes one marker unreliable?
A useful example is medication safety in an older adult with frailty. Creatinine might give an eGFR of 72 because the person produces very little creatinine. Cystatin C might give 43. The combined estimate might land around 53. That middle number is often safer for drug review than assuming the kidneys function like an eGFR of 72.
Another example is a strength athlete with a creatinine eGFR of 59 and a cystatin C eGFR of 92. If urine albumin is normal and prior results are stable, the creatinine estimate may be overly pessimistic. The person still deserves proper follow-up, but the cystatin C result can prevent unnecessary alarm.
Limits and factors that affect accuracy
Cystatin C is useful, but it is not a perfect kidney test. It is less affected by muscle mass than creatinine, but it has its own non-kidney influences. The goal is not to find a flawless marker. The goal is to choose the marker, or combination of markers, that best fits the person.
Conditions and factors that can affect cystatin C include:
- Thyroid disease, especially untreated or changing thyroid hormone levels
- High-dose corticosteroid treatment
- Inflammation or serious infection
- Smoking
- Obesity and higher fat mass
- Some cancers or severe systemic illness
- Recent hospitalization or acute medical stress
These factors do not make the test useless. They tell the clinician to interpret it carefully. For example, a person on high-dose prednisone for an autoimmune flare might have a higher cystatin C level that partly reflects steroid exposure, not only kidney filtration. A person with uncontrolled thyroid disease might need repeat testing after thyroid levels stabilize.
Lab standardization also matters. Modern cystatin C testing should be calibrated to accepted reference materials. If cystatin C is measured by a non-standardized method, the eGFR equation becomes less trustworthy. Most large laboratories follow current standards, but unusual results should be checked against the lab method, the equation used, and the clinical situation.
Cystatin C also does not diagnose the cause of kidney disease. It estimates filtration. It cannot tell whether the problem is diabetes, high blood pressure, glomerulonephritis, obstruction, medication injury, inherited disease, or something else. If kidney disease is confirmed, the cause usually requires urine testing, blood pressure review, medication review, imaging, diabetes assessment, and sometimes specialist evaluation.
The test is less helpful in fast-changing acute illness. eGFR equations work best when kidney markers are relatively stable. During sudden dehydration, sepsis, major surgery, acute kidney injury, or rapidly changing creatinine, any estimated GFR can lag behind real-time kidney function. In that setting, clinicians use repeated labs, urine output, clinical signs, and sometimes direct measurement or hospital protocols.
Cost and access are practical limits. Cystatin C is not included in every routine panel. Insurance coverage varies. Some clinics send it to an outside lab, which delays results. That is why it is often ordered when the answer changes a decision rather than as a routine add-on.
How to prepare and what to ask your doctor
A cystatin C test is a standard blood draw. Most people do not need to fast. You usually do not need a special diet, timed urine collection, or medication pause unless your clinician gives specific instructions.
Still, the result is easier to interpret if your doctor knows what might affect it. Before the test or at the follow-up visit, mention:
- Creatine supplements, bodybuilding supplements, or recent changes in protein intake
- High-dose steroid medicines such as prednisone
- Known thyroid disease or recent thyroid medication changes
- Recent infection, hospitalization, surgery, or inflammatory flare
- Major weight loss, frailty, amputation, or muscle-wasting conditions
- Pregnancy or recent pregnancy
- Any medicines that were started, stopped, or dose-adjusted recently
Ask what result the clinician plans to use. The most useful question is not “Is my cystatin C normal?” It is “What is my eGFR using creatinine and cystatin C together, and does it change my kidney stage or treatment plan?”
Good follow-up questions include:
- Was my combined eGFR higher or lower than my creatinine-based eGFR?
- Does this result confirm chronic kidney disease or make it less likely?
- Should any medicine doses be reviewed using the combined estimate?
- Do I need a urine albumin-to-creatinine ratio?
- Should this be repeated, and if so, when?
- Which eGFR equation is my lab using?
If the result is unexpected, repeating it can be reasonable. A repeat test is especially useful when the person had a recent illness, steroid course, thyroid change, or lab result that does not fit prior trends. For chronic kidney disease, persistence over at least three months is often part of the diagnosis, so a single borderline result should not be treated as the whole story.
Bring prior lab reports if you have them. Trends across the same lab and equation are easier to interpret than isolated numbers from different systems. If your lab changed equations, an apparent jump or drop might partly reflect the calculation change rather than a real shift in kidney function.
How cystatin C fits into kidney care
Cystatin C is one part of a kidney evaluation, not the whole evaluation. A complete picture usually includes eGFR, urine albumin, blood pressure, diabetes status, medication review, and sometimes imaging. Symptoms are often absent in early kidney disease, so lab patterns matter more than how a person feels.
The most useful role for cystatin C is confirmation. It helps confirm whether a creatinine-based eGFR is likely accurate, especially when the result affects diagnosis, staging, medication safety, or referral. A combined creatinine-cystatin C estimate often gives the clearest routine estimate of filtration in adults.
For people already diagnosed with chronic kidney disease, cystatin C can sharpen staging and risk prediction. It can also help identify people whose creatinine-based estimate underestimates risk. That matters because earlier recognition leads to better blood pressure control, safer medication choices, kidney-protective treatment when appropriate, and more consistent monitoring.
Cystatin C does not replace healthy kidney basics. If kidney disease is present or likely, the core steps still include controlling blood pressure, managing diabetes, avoiding unnecessary NSAID use, reviewing medication doses, checking urine albumin, and following an individualized monitoring plan. Diet changes depend on CKD stage, potassium, phosphorus, urine findings, and other health issues; they should not be guessed from cystatin C alone.
A nephrology referral is more likely when eGFR is clearly reduced, falling quickly, paired with significant albumin in the urine, associated with blood or abnormal urine findings, or difficult to explain. If you are unsure whether specialist care is needed, the guide on when to see a nephrologist covers common referral reasons.
The practical takeaway is simple: cystatin C is worth asking about when creatinine does not fit the person. It is especially valuable when muscle mass, supplements, frailty, or a borderline decision point make the standard eGFR uncertain. The best result is often not cystatin C alone, but the combined eGFR that uses both markers to reduce guesswork.
References
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race 2021
- A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease 2021 (Position Statement)
- National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories 2022 (Guidance)
- Cystatin C–Based Equation to Estimate GFR without the Inclusion of Race and Sex 2023
- CKD Evaluation and Management 2024 (Guideline)
- Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis 2025 (Systematic Review)
Disclaimer
This article is for education and does not diagnose kidney disease or replace medical care. Cystatin C results should be interpreted with your creatinine, urine albumin, medications, body composition, health conditions, and prior lab trends. Ask a qualified clinician how the result affects your diagnosis, drug dosing, monitoring schedule, or need for nephrology referral.
